Assessment of remifentanil for rapid sequence induction and intubation in patients at risk of pulmonary aspiration of gastric contents compared to rapid-onset paralytic agents: study protocol for a non-inferiority simple blind randomized controlled trial (the REMICRUSH study)

Peer Review reports

Original Submission
10 Jan 2021	Submitted	Original manuscript
18 Feb 2021	Reviewed	Reviewer Report - Riaz Qureshi
6 Mar 2021	Author responded	Author comments - Nicolas Grillot
Resubmission - Version 2
6 Mar 2021	Submitted	Manuscript version 2
14 Mar 2021	Reviewed	Reviewer Report - Riaz Qureshi
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
15 Mar 2021	Editorially accepted
30 Mar 2021	Article published	10.1186/s13063-021-05192-x

Back to article page